Comparison of Transcutaneous and Arterial Carbon Dioxide Sampling During Jet Ventilation, a Prospective. Study on Patients Undergoing Percutaneous Liver Tumour Radiofrequency Ablation

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSahlgrenska University Hospital

About this trial

The study aims to compare the readings from two methods of monitoring carbon dioxide levels during jet ventilation when normal end-tidal monitoring is not possible. During jet ventilation it is technically not possible to monitor the levels of carbon dioxide in exhaled air as is the standard in preoperative care. We will compare transcutaneous (through the skin) monitoring to an arterial blood. sample. Both transcutaneous monitoring and arterial monitoring is currently used as the standard for this patient group at our institution. By collecting data prospectively we can evaluate if there. are discrepancies based on monitoring method. All patients will be treated per standard preoperative protocol and only patients consenting to participate will contribute data to the comparison and statistical analysis.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

adult patients undergoing percutaneous RF liver tumour ablation requiring jet ventilation

Disqualifiers

disease or condition. not compatible with jet ventilation

Trial population

Adults undergoing percutaneous RF liver ablation under jet ventilation

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

  • No Interventions

    Other intervention

    No intervention, solely data collection

Treatment groups

100 Participants
are divided into 1 treatment group
Group A: jet_ventilation1 intervention

Trial outcomes

Primary outcomes

1

Difference in CO2 between TcCO2 and PaCO2

Time frame
during perioperative management

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.